Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis

Relapse of FLT3‐mutated acute myeloid leukemia (AML) following allogeneic stem cell transplantation is associated with poor survival. The clinical utility of sorafenib monotherapy in this setting is described in a patient presenting as leukemia cutis.

Detalles Bibliográficos
Autores principales: Brodie, Rachel, Langabeer, Stephen E., Quinn, John, McMenamin, Máirín E., Hayden, Patrick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935638/
https://www.ncbi.nlm.nih.gov/pubmed/31893105
http://dx.doi.org/10.1002/ccr3.2487
_version_ 1783483608328044544
author Brodie, Rachel
Langabeer, Stephen E.
Quinn, John
McMenamin, Máirín E.
Hayden, Patrick J.
author_facet Brodie, Rachel
Langabeer, Stephen E.
Quinn, John
McMenamin, Máirín E.
Hayden, Patrick J.
author_sort Brodie, Rachel
collection PubMed
description Relapse of FLT3‐mutated acute myeloid leukemia (AML) following allogeneic stem cell transplantation is associated with poor survival. The clinical utility of sorafenib monotherapy in this setting is described in a patient presenting as leukemia cutis.
format Online
Article
Text
id pubmed-6935638
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69356382019-12-31 Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis Brodie, Rachel Langabeer, Stephen E. Quinn, John McMenamin, Máirín E. Hayden, Patrick J. Clin Case Rep Clinical Image Relapse of FLT3‐mutated acute myeloid leukemia (AML) following allogeneic stem cell transplantation is associated with poor survival. The clinical utility of sorafenib monotherapy in this setting is described in a patient presenting as leukemia cutis. John Wiley and Sons Inc. 2019-10-19 /pmc/articles/PMC6935638/ /pubmed/31893105 http://dx.doi.org/10.1002/ccr3.2487 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Image
Brodie, Rachel
Langabeer, Stephen E.
Quinn, John
McMenamin, Máirín E.
Hayden, Patrick J.
Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis
title Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis
title_full Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis
title_fullStr Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis
title_full_unstemmed Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis
title_short Sorafenib for relapsed FLT3‐ITD‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis
title_sort sorafenib for relapsed flt3‐itd‐positive acute myeloid leukemia postallogeneic stem cell transplantation presenting as leukemia cutis
topic Clinical Image
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935638/
https://www.ncbi.nlm.nih.gov/pubmed/31893105
http://dx.doi.org/10.1002/ccr3.2487
work_keys_str_mv AT brodierachel sorafenibforrelapsedflt3itdpositiveacutemyeloidleukemiapostallogeneicstemcelltransplantationpresentingasleukemiacutis
AT langabeerstephene sorafenibforrelapsedflt3itdpositiveacutemyeloidleukemiapostallogeneicstemcelltransplantationpresentingasleukemiacutis
AT quinnjohn sorafenibforrelapsedflt3itdpositiveacutemyeloidleukemiapostallogeneicstemcelltransplantationpresentingasleukemiacutis
AT mcmenaminmairine sorafenibforrelapsedflt3itdpositiveacutemyeloidleukemiapostallogeneicstemcelltransplantationpresentingasleukemiacutis
AT haydenpatrickj sorafenibforrelapsedflt3itdpositiveacutemyeloidleukemiapostallogeneicstemcelltransplantationpresentingasleukemiacutis

Ejemplares similares